Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.
A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...
There are a few unusual things about the infant botulism outbreak that prompted formula maker ByHeart to recall all of its ...
There are many reasons why a 79-year-old man might need to get an MRI scan of his brain, some benign, some more concerning.
The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.
Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...
Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...
What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
FDA Commissioner Marty Makary and biologics chief Vinay Prasad have sketched out the agency’s first real blueprint for ...
Read more from STAT’s Chelsea Cirruzzo and Daniel Payne for more details on what Vance had to say and what attendees received ...
Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results